Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.

Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.

1989 • 1,540 citations

A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma

1989 • 1,494 citations

Normal Histology of the Prostate

1988 • 658 citations

Prostatic Intra-Epithelial Neoplasia and Early Invasion in Prostate Cancer

1987 • 536 citations

The Present Status of Radical Prostatectomy for Stages A and B Prostatic Cancer

1975 • 445 citations

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

1993 • 380 citations

The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic Hyperplasia

1987 • 334 citations

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.

1990 • 314 citations

Antifertility Effects of LHRH Agonists in the Male

1980 • 197 citations

Hormonal Therapy of Prostatic Cancer

1980 • 195 citations

The Effect of Castration on Benign Hypertrophy of the Prostate in Man

1940 • 173 citations

Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy

1984 • 162 citations

Pathologic changes associated with androgen deprivation therapy for prostate cancer

1991 • 161 citations

Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic Adenocarcinoma

1991 • 129 citations

The Treatment of Benign Prostatic Hypertrophy with Flutamide (SCH 13521): A Placebo-Controlled Study

1975 • 116 citations

Cardiovascular Complications in the Treatment of Prostatic Carcinoma

1981 • 92 citations

The role of neoadjuvant hormonal manipulation in localized prostatic cancer

1993 • 88 citations

Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma

1992 • 88 citations

Growth fractions in human prostatic carcinoma determined by Ki‐67 immunostaining

1988 • 71 citations

Determination of growth fraction in advanced prostate cancer by KI-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy

1991 • 67 citations

Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters events that accompany tumor regression

1990 • 64 citations

Application of the Monoclonal Antibody Ki-67 on Prostate Biopsies to Assess the Proliferative Cell Fraction of Human Prostatic Carcinoma

1991 • 60 citations

Cell Proliferation in Prostatic Adenocarcinoma: In Vitro Measurement by 5-Bromodeoxyuridine Incorporation and Proliferating Cell Nuclear Antigen Expression

1993 • 56 citations

Prostatic intra-epithelial neoplasia: Expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei

1993 • 47 citations

Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia

1993 • 35 citations

Response of the Benign Hypertrophied Prostate to Treatment with an LHRH Analogue

1988 • 35 citations

Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D‐Trp‐6‐LH‐RH

1988 • 30 citations

Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate

1987 • 23 citations

Reproducibility of mitotic counts and identification of mitotic figures in malignant glial tumors.

1988 • 22 citations

Prostatic Invasive Adenocarcinoma

1993 • 20 citations

Treated prostatic carcinoma. Histological, immunohistochemical and cell kinetic studies.

1985 • 19 citations

Nonsurgical treatment of prostatic hyperplasia

1992 • 14 citations

Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus.

1993 • 5 citations

Quantitative Untersuchungen zum Zellverlust in Prostatacarcinomen Klinisch-morphologische Aspekte

1981 • 2 citations